Gris-PEG (Griseofulvin Ultramicrosize) Tablets, 125 & 250 mg, Pedinol Pharmacal, NDA 50-475/S-046 GRISEOFULVIN, MICROCRYSTALLINE Suspension; 125MG/5ML GRIFULVIN V J AND J 062279 GRISEOFULVIN, MICROCRYSTALLINE Tablet; 125MG GRIFULVIN V J AND J | 062279 GRISEOFULVIN, MICROCRYSTALLINE Tablet; 250MG GRIFULVIN V J AND J | 062279 GRISEOFULVIN, MICROCRYSTALLINE Tablet; 500MG GRIFULVIN V J AND J | 060569 GRISEOFULVIN, MICROCRYSTALLINE Tablet; 250MG FULVICIN-U/F SCHERING | 060569 GRISEOFULVIN, MICROCRYSTALLINE Tablet; 500MG FULVICIN-U/F SCHERING | 050475 GRISEOFULVIN, ULTRAMICROCRYSTALLINE Tablet; 125MG GRIS-PEG PEDINOL | 050475 GRISEOFULVIN, ULTRAMICROCRYSTALLINE Tablet; 250MG GRIS-PEG PEDINOL | 061996 GRISEOFULVIN, ULTRAMICROCRYSTALLINE Tablet; 125MG FULVICIN P/G SCHERING | 061996 GRISEOFULVIN, ULTRAMICROCRYSTALLINE Tablet; 165MG FULVICIN P/G 165 SCHERING | 061996 GRISEOFULVIN, ULTRAMICROCRYSTALLINE Tablet; 250MG FULVICIN P/G SCHERING | 061996 GRISEOFULVIN, ULTRAMICROCRYSTALLINE Tablet; 330MG FULVICIN P/G 330 SCHERING | Griseofulvin Oral Suspension, Stiefel Laboratories, Approval

For the most up-to-date approval information, please locate this API using the drug index. For industry specific content, please visit USActives.com.